Literature DB >> 21642822

A primary care focus on the treatment of patients with major depressive disorder.

Karen Weihs1, Jonathan M Wert.   

Abstract

Major depressive disorder (MDD) is a common psychiatric illness affecting nearly 20% of adults in the United States at least once during their lifetime. MDD is frequently diagnosed and treated in the primary care setting. Management of the disease may be complicated by patients and family members feeling stigmatized by the diagnosis and not understanding that depression is a treatable medical illness, which, in turn, fosters low rates of adherence to treatment recommendations. Incomplete or delayed response to treatment, adverse events associated with antidepressants and medical or psychiatric comorbidities also interfere with optimal depression management. This article presents an overview of diagnostic and treatment guidelines for MDD and focuses on challenges encountered by primary care physicians. The role of antidepressant medications, psychotherapy and nonpharmacologic interventions for the treatment of patients with MDD is described, and factors influencing treatment selection, such as adverse event profiles and patient characteristics, are examined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642822      PMCID: PMC3170663          DOI: 10.1097/MAJ.0b013e318210ff56

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  53 in total

1.  Delayed effects of antidepressant drugs in rats.

Authors:  Maciej Kuśmider; Agata Faron-Górecka; Marta Dziedzicka-Wasylewska
Journal:  Behav Pharmacol       Date:  2006-12       Impact factor: 2.293

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

3.  Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes.

Authors:  F A Moreno; G R Heninger; C A McGahuey; P L Delgado
Journal:  Biol Psychiatry       Date:  2000-08-15       Impact factor: 13.382

4.  Predicting onset of depression: the Vulnerability to Depression Questionnaire.

Authors:  P M Moran; A Bifulco; C Ball; C Campbell
Journal:  Br J Clin Psychol       Date:  2001-11

5.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

Review 6.  St John's wort for major depression.

Authors:  Klaus Linde; Michael M Berner; Levente Kriston
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

7.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 8.  Review: Bupropion and SSRI-induced side effects.

Authors:  K Demyttenaere; L Jaspers
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

9.  Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care.

Authors:  Kathryn Rost; Paul Nutting; Jeffrey L Smith; Carl E Elliott; Miriam Dickinson
Journal:  BMJ       Date:  2002-10-26

Review 10.  Depression during pregnancy: rates, risks and consequences--Motherisk Update 2008.

Authors:  Sheila M Marcus
Journal:  Can J Clin Pharmacol       Date:  2009-01-22
View more
  8 in total

1.  PURLs: Light therapy for nonseasonal major depressive disorder?

Authors:  Kehinde Eniola; Angela Bacigalupo; Anne Mounsey
Journal:  J Fam Pract       Date:  2016-07       Impact factor: 0.493

2.  Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis.

Authors:  Colin B Josephson; Mark Lowerison; Isabelle Vallerand; Tolulope T Sajobi; Scott Patten; Nathalie Jette; Samuel Wiebe
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

3.  A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort.

Authors:  P M Bet; E C Verbeek; Y Milaneschi; D B M Straver; T Uithuisje; M R Bevova; J G Hugtenburg; P Heutink; B W J H Penninx; W J G Hoogendijk
Journal:  Pharmacogenomics J       Date:  2015-05-19       Impact factor: 3.550

4.  Is placebo useful in the treatment of major depression in clinical practice?

Authors:  Carlo Marchesi; Chiara De Panfilis; Matteo Tonna; Paolo Ossola
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-25       Impact factor: 2.570

5.  Antidepressants: relationship to the time to psychiatric readmission and probability of being in hospital in depressive patients.

Authors:  Ingeborg Warnke; Carlos Nordt; Jörn Moock; Wolfram Kawohl; Wulf Rössler
Journal:  Front Public Health       Date:  2014-05-08

Review 6.  Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD).

Authors:  C Brendan Montano; W Clay Jackson; Denise Vanacore; Richard H Weisler
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-12       Impact factor: 2.989

Review 7.  The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review.

Authors:  Madelon L J M van Hees; Thomas Rotter; Tim Ellermann; Silvia M A A Evers
Journal:  BMC Psychiatry       Date:  2013-01-11       Impact factor: 3.630

Review 8.  Antidepressant efficacy and side-effect burden: a quick guide for clinicians.

Authors:  Daniel Santarsieri; Thomas L Schwartz
Journal:  Drugs Context       Date:  2015-10-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.